Recent Updates
Recently added Catalysts
ZBH

E. Main St. Warsaw, IN 46580 www.zimmerbiomet.com Contacts: Media Investors Monica Kendrick 574-372-4989 Coleman Lannum 574-371-9480 monica.kendrick@zimmerbiomet.com cole.lannum@zimmerbiomet.com Derek Davis 574-372-4250

Key Takeaway: www.zimmerbiomet.com Media Investors Monica Kendrick 574-372-4989 Coleman Lannum 574-371-9480 monica.kendrick@zimmerbiomet.com cole.lannum@zimmerbiomet.com Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado and Syed Jafry to Board of Directors Hilado and Jafry Bring Financ

Full Press Release Details

Media Investors
Monica Kendrick 574-372-4989 Coleman Lannum 574-371-9480
monica.kendrick@zimmerbiomet.com cole.lannum@zimmerbiomet.com
Zimmer Biomet Appoints Maria Teresa (Tessa) Hilado and
Syed Jafry to Board of Directors
Hilado and Jafry Bring Financial Acumen and Global Experience
to Board of Directors
August 3, 2018 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that Maria Teresa (Tessa) Hilado, former Executive Vice President and Chief Financial Officer of Allergan PLC,
and Syed Jafry, Senior Vice President and President, Asia Pacific, EMEA and Emerging Markets, Thermo Fisher Scientific Inc., have been appointed to the Company s Board of Directors, effective immediately.
We are pleased to welcome Tessa Hilado and Syed Jafry to our Board of Directors. Ms. Hilado s deep financial and leadership expertise and
Mr. Jafry s diverse skill set and breadth of global experience will be invaluable assets to Zimmer Biomet, said Larry Glasscock, Chairman of the Board, Zimmer Biomet Holdings, Inc. The addition of these new Board members
demonstrates our commitment and steady focus on growing diversity within our organization and the healthcare industry. We look forward to their contributions as we continue to drive our strategic goals.
Ms. Hilado brings more than 30 years of financial and leadership experience to Zimmer Biomet. Most recently,
she served as Executive Vice President and Chief Financial Officer of Allergan PLC, a global pharmaceutical company, from December 2014 until her retirement in February 2018. Prior to joining Allergan PLC, Ms. Hilado held the role of Senior
Vice President, Finance and Treasurer of PepsiCo Inc. from 2009 to 2014. She previously served as Vice President and Treasurer for Schering-Plough Corp. and spent more than 17 years with General Motors Company in leadership roles of increasing
Ms. Hilado currently serves on the board of directors of Campbell Soup Company, H.B. Fuller Company and Pharmaceutical Product
Development, LLC. She earned a Bachelor of Science in Management Engineering from Ateneo de Manila University in the Philippines and an MBA from the University of Virginia Darden School of Business.
Mr. Jafry has more than 30 years of global operations and management experience in healthcare, infrastructure, energy and chemical industries. He
currently serves as Senior Vice President and President, Asia Pacific, EMEA and Emerging Markets of Thermo Fisher Scientific Inc., a global leader in serving science, supporting customers in pharmaceutical, healthcare, diagnostics and research
markets. He joined Thermo Fisher Scientific Inc. in March 2005 and served in numerous P&L management roles of increasing responsibility prior to being appointed to his current position. Mr. Jafry began his career at Glaxo Pharmaceuticals in
London. Prior to joining Thermo Fisher Scientific, he served for 18 years at General Electric, where he held commercial, product management and general management roles in the U.S., Netherlands, Switzerland and China, with his role as President of
GE Sensing Asia. He earned a Bachelor of Science in Mechanical Engineering from Lahore University in Pakistan, a Master of Science in Mechanical Engineering from the University of Massachusetts and a Master s Certificate in Marketing and
Management from Harvard University Extension School.
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market
orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from
disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information,
visit www.zimmerbiomet.com, or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
Last updated: Aug 3, 2018